Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-05

Clinical Trial Update: GDF15 Based TPF Induction Chemotherapy for OSCC Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating GDF15-based induction chemotherapy for oral squamous cell carcinoma (OSCC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GDF15-based induction chemotherapy (GDF15-based induction chemotherapy)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Mouth Neoplasms, Carcinoma, Squamous Cell | Phase 2 | Status: UNKNOWN